MedTrace Logo

Green Tea Anticancer Mechanisms in Smokers

NCT01162642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2015-04-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether green tea may lower the risk of certain cancers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Green Tea

Green Tea 4 cups daily

OTHER

Placebo

4 cups placebo tea for 6 weeks

Sponsors & Collaborators

  • Philip Diaz

    lead OTHER

Principal Investigators

  • Philip Diaz, M.D. · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162642 on ClinicalTrials.gov